Pilot Biotechnology

company

About

Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.

  • 501 - 1000

Details

Last Funding Type
Series C
Industries
Biopharma,Biotechnology,Health Care,Manufacturing,Medical,Pet
Founded date
Jan 1, 2015
Number Of Employee
501 - 1000
Operating Status
Active

Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzyme engineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥100M
Pilot Biotechnology has raised a total of ¥100M in funding over 2 rounds. Their latest funding was raised on Feb 8, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 8, 2022 Series C ¥100M 1 Lilly Asia Ventures Detail
Dec 16, 2021 Series C 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Pilot Biotechnology is funded by 2 investors. Lilly Asia Ventures and New Hope Sichuan Venture Capital Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures Yes Series C
New Hope Sichuan Venture Capital Fund Series C